Morepen Laboratories Limited

rs,

Subject: Investor Presentation – Q2’ FY26 Dear Sir/ Madam, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288 Please find enclosed the Investor Presentation –

34%

Executive Summary Business Segments: Business Segments: Medical Devices Pharma Business API+Rx 34% Share of Medical Devices 66% Share of Pharma Business 1Point of CareQ2'FY 26standAlone Executiv

66%

ments: Business Segments: Medical Devices Pharma Business API+Rx 34% Share of Medical Devices 66% Share of Pharma Business 1Point of CareQ2'FY 26standAlone Executive Summary standalone revenue:

27.7%

API Product-wise breakup: Product-wise breakup: PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-w

24.4%

e breakup: Product-wise breakup: PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-wise share: Conti

rs13.7

: Product-wise breakup: PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-wise share: Continent-wise

13%

se breakup: PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-wise share: Continent-wise share: H

12.4%

kup: PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-wise share: Continent-wise share: H1'26 Q2

4.7%

DUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-wise share: Continent-wise share: H1'26 Q2 FY 26 E

4%

re API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API Continent-wise share: Continent-wise share: H1'26 Q2 FY 26 Europe3

31.6%

%3Q2'FY 26 pHarma Business/API Continent-wise share: Continent-wise share: H1'26 Q2 FY 26 Europe31.6%India28.5%Asia21.7%USA14.8%S. America3.4%3Europe30.6%India26.9%Asia26.2%USA12.7%S. America3.6%Q2'FY

28.5%

pHarma Business/API Continent-wise share: Continent-wise share: H1'26 Q2 FY 26 Europe31.6%India28.5%Asia21.7%USA14.8%S. America3.4%3Europe30.6%India26.9%Asia26.2%USA12.7%S. America3.6%Q2'FY 26 Pharma

“PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API”

Quarterly Performance

2

Business Segments

1

Top selling Products

1

Total revenue

1

BP Monitor revenue

1

Total Pharma revenue

1

Product-wise breakup

1

Continent-wise share

1

API revenue

1

Business Segments

Medical Devices Pharma Business API+Rx 34% Share of Medical Devices 66% Share of Pharma Business 1Point of CareQ2'FY 26standAlone Executive Summary standalone revenue: standalone revenue: H1 Revenue quarterly Revenue 1H1'25H1'260200400600800777770Q2'FY25Q2'FY260100200300400388374Rs. in CroresRs. in CroresRs. in CroresRs. in CroresQ2'FY 26 2 Medical devices Q2'FY 26 Medical Devices

Top selling Products

ThermometersNebulisersPregnancy KitsOrtho supports2Blood Glucose metersBP MonitorsQ2'FY 26 Medical Devices

Total revenue

H1 quarterly Revenue H1'25H1'26050100150200250300271287Q2'FY25Q2'FY26020406080100120140133126Q2'FY 26Rs. in CroresRs. in CroresRs. in CroresRs. in Crores2 Medical Devices glucometer revenue : glucometer revenue : 16.1 mn gluco meters sold quarterly Revenue Q2'FY25Q2'FY2602040608010012010397Q2'FY 26Rs. in CroresRs. in Crores2Happy customer base Medical Devices

BP Monitor revenue

quarterly Revenue Q2'FY25Q2'FY2605101520252323Q2'FY 26Rs. in CroresRs. in Crores2Market Leaders forBP Monitors#1 3 Pharma Business Pharma Business

Total Pharma revenue

H1 Revenue quarterly Revenue H1'25H1'260100200300400500600506483Q1'FY26Q2'FY26050100150200250235248Rs. in CroresRs. in CroresRs. in CroresRs. in Crores3Q2'FY 26 pHarma Business/API

Product-wise breakup

PRODUCT share API revenue split Q2'FY26 Atorva27.7%Lorata +Des24.4%Others13.7%Monte13%Rosu12.4%Fexo4.7%Dapa4%3Q2'FY 26 pHarma Business/API